- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有492家主力机构披露2025-06-30报告期持股数据，持仓量总计34.90亿股，占流通A股69.21%
- 波段诊断：
-
技术面诊股
诊断结果：5.8技术面打败了40%的股票
技术面评分前10的股票
近期的平均成本为4.97元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为4.97元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.97","date":1761468393,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.10.27","stock":"0.20","trade":"0.74","ind":"1.18"},{"date":"2025.10.24","stock":"-1.20","trade":"-1.06","ind":"0.71"},{"date":"2025.10.23","stock":"0.00","trade":"1.04","ind":"0.22"},{"date":"2025.10.22","stock":"1.01","trade":"0.90","ind":"-0.07"},{"date":"2025.10.21","stock":"1.02","trade":"0.84","ind":"1.36"},{"date":"2025.10.20","stock":"0.61","trade":"1.39","ind":"0.63"},{"date":"2025.10.17","stock":"-1.01","trade":"-0.87","ind":"-1.95"},{"date":"2025.10.16","stock":"0.20","trade":"-0.39","ind":"0.10"},{"date":"2025.10.15","stock":"0.20","trade":"1.24","ind":"1.22"},{"date":"2025.10.14","stock":"0.00","trade":"0.15","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.61","trade":"-1.12","ind":"-0.19"},{"date":"2025.10.10","stock":"0.41","trade":"0.25","ind":"-0.94"},{"date":"2025.10.09","stock":"1.44","trade":"0.06","ind":"1.32"},{"date":"2025.09.30","stock":"-0.82","trade":"-0.53","ind":"0.52"},{"date":"2025.09.29","stock":"0.41","trade":"0.32","ind":"0.90"},{"date":"2025.09.26","stock":"-0.20","trade":"-1.25","ind":"-0.65"},{"date":"2025.09.25","stock":"-1.21","trade":"-0.95","ind":"-0.01"},{"date":"2025.09.24","stock":"0.00","trade":"0.84","ind":"0.83"},{"date":"2025.09.23","stock":"-0.40","trade":"-1.00","ind":"-0.18"},{"date":"2025.09.22","stock":"-0.60","trade":"-0.77","ind":"0.22"},{"date":"2025.09.19","stock":"-0.60","trade":"-2.31","ind":"-0.30"}]
九州通,上证指数,医药商业指数
压力支撑
该股压力位为4.96元，支撑位为4.94元。
[{"text":"\u538b\u529b\u4f4d","value":"4.96","date":1761494400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.94","date":1761494400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.6资金面打败了81%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金总体无进出。
更新时间：10月28日 08:11
| 机构今日流向(万元) | 10.97 | 机构5日流向(万元) | -292.04 |
| 机构10日流向(万元) | -1774.66 | 机构20日流向(万元) | -13217.77 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1794.22万股，其中基金净减仓14家，主力净增仓134家，请投资者中长期谨慎为宜。
截止2025-06-30，共492家主力机构（基金483家，一般法人9家），持仓量总计349001万股，占流通A股69.21%
其中，基金持仓与2024-12-31相比：
增仓：98家 ，增持 4731.88万股
减仓：112家 ，减持 2716.54万股
新出现在主力名单中：256家 ，持有15503.76万股
从主力名单中消失：122家 ，原持有13542.51万股
其中，基金持仓与2024-12-31相比：
增仓：98家 ，增持 4731.88万股
减仓：112家 ，减持 2716.54万股
新出现在主力名单中：256家 ，持有15503.76万股
从主力名单中消失：122家 ，原持有13542.51万股
消息面诊股
诊断结果：5.6消息面打败了59%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 九州通：10月27日获融资买入1291.27万元
2025-10-28 - 最新！社保基金重仓这些业绩增长股
2025-10-28 - 股东追踪|全国社保基金六零四组合新进九州通前十大流
2025-10-27 - “三新两化”战略落地生根 九州通2025年前三季度
2025-10-27 - 前三季度营收近1200亿元 九州通新产品战略助力业
2025-10-27 - 九州通（截止2025年9月30日）股东人数为569
2025-10-27 - 九州通：第三季度净利润5.3亿元，同比增长8.46
2025-10-27 - 九州通：盐酸多巴胺注射液上市许可持有人变更为汇禹远
2025-10-27 - 九州通医疗器械集团等在河南成立新公司 注册资本10
2025-10-27 - 九州通等成立中药材公司
2025-10-27
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-09-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-27 |
| 一般消息 | 募资投向 | 2025-08-05 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-05 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-15 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-29 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-04-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-29 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-20 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-09 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.0行业面打败了96%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.10.27","price":"1.18","value":"0.74"},{"date":"2025.10.24","price":"0.71","value":"-1.06"},{"date":"2025.10.23","price":"0.22","value":"1.04"},{"date":"2025.10.22","price":"-0.07","value":"0.90"},{"date":"2025.10.21","price":"1.36","value":"0.84"},{"date":"2025.10.20","price":"0.63","value":"1.39"},{"date":"2025.10.17","price":"-1.95","value":"-0.87"},{"date":"2025.10.16","price":"0.10","value":"-0.39"},{"date":"2025.10.15","price":"1.22","value":"1.24"},{"date":"2025.10.14","price":"-0.62","value":"0.15"},{"date":"2025.10.13","price":"-0.19","value":"-1.12"},{"date":"2025.10.10","price":"-0.94","value":"0.25"},{"date":"2025.10.09","price":"1.32","value":"0.06"},{"date":"2025.09.30","price":"0.52","value":"-0.53"},{"date":"2025.09.29","price":"0.90","value":"0.32"},{"date":"2025.09.26","price":"-0.65","value":"-1.25"},{"date":"2025.09.25","price":"-0.01","value":"-0.95"},{"date":"2025.09.24","price":"0.83","value":"0.84"},{"date":"2025.09.23","price":"-0.18","value":"-1.00"},{"date":"2025.09.22","price":"0.22","value":"-0.77"},{"date":"2025.09.19","price":"-0.30","value":"-2.31"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 大参林 | 6.11% | 0.05% | 6.6分 |
| 2 | 达嘉维康 | 5.48% | 3.15% | 6.0分 |
| 3 | 华人健康 | 3.38% | 4.18% | 6.2分 |
| 4 | 英特集团 | 2.89% | 0.89% | 5.8分 |
| 5 | 嘉事堂 | 2.87% | 1.23% | 5.9分 |
| 6 | 鹭燕医药 | 2.80% | 1.20% | 5.9分 |
| 8 | 南京医药 | 2.62% | 1.80% | 6.5分 |
| 10 | 重药控股 | 2.11% | 1.33% | 5.6分 |
| 12 | 国药股份 | 1.89% | 3.56% | 5.9分 |
| 14 | 人民同泰 | 0.62% | -0.49% | 6.0分 |
| 16 | 合富中国 | -0.15% | 4.37% | 6.0分 |
| 18 | 九州通 | -0.60% | 1.02% | 6.2分 |
| 20 | 健之佳 | -1.02% | 1.77% | 6.7分 |
| 22 | 国科恒泰 | -1.55% | 2.66% | 5.4分 |
| 24 | 一心堂 | -2.52% | 0.36% | 4.6分 |
| 26 | 老百姓 | -2.74% | 0.18% | 5.3分 |
| 28 | 润达医疗 | -8.16% | 3.17% | 5.7分 |
| 30 | 百洋医药 | -9.47% | 2.37% | 5.3分 |
| 32 | 建发致新 | - | 34.10% | 6.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国信证券 | 2012-09-12 | 增持 | 增持 |
| 国海证券 | 2012-09-11 | 中性 | - |
| 东兴证券 | 2012-09-11 | 增持 | 增持 |
| 平安证券 | 2012-09-10 | 增持 | 增持 |
| 华融证券 | 2012-09-10 | 中性 | 中性 |
更多>>行业资讯
- 2012-09-13海岛建设股东股权质押
- 2012-09-13工大首创简式权益变动
- 2012-09-13华联综超选举公司第五届董事会董事长
- 2012-09-13积极追随政策把握市场热点方向
- 2012-09-13商贸零售行业：行业拐点仍需等待 选择确定性增长公司
- 2012-09-13卡奴迪路调研简报：渠道逆势持续扩张 明年增长新亮点
- 2012-09-13传言家乐福将退出中国市场 专家称可能性甚微
- 2012-09-13外资零售巨头在华遭遇困顿 专家分析八大原因
- 2012-09-13外资零售企业也须与时俱进
- 2012-09-13商务部谈电商价格战：正起草电子商务管理条例
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 10/74 ， 26/74。
[{"date":"2025-06-30","value":"5.26","vol":"3.26"},{"date":"2025-03-31","value":"3.50","vol":"1.75"},{"date":"2024-12-31","value":"9.79","vol":"4.53"},{"date":"2024-09-30","value":"6.73","vol":"5.85"},{"date":"2024-06-30","value":"5.00","vol":"4.30"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.26 | 3.50 | 9.79 | 6.73 | 5.00 |
| 行业(%) | 3.26 | 1.75 | 4.53 | 5.85 | 4.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"7.56","vol":"17.29"},{"date":"2025-03-31","value":"7.33","vol":"17.11"},{"date":"2024-12-31","value":"7.80","vol":"17.34"},{"date":"2024-09-30","value":"7.96","vol":"17.89"},{"date":"2024-06-30","value":"7.92","vol":"17.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
7.56 | 7.33 | 7.80 | 7.96 | 7.92 |
| 行业(%) | 17.29 | 17.11 | 17.34 | 17.89 | 17.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/74 ， 7/74。
[{"date":"2025-06-30","value":"5.10","vol":"-3.59"},{"date":"2025-03-31","value":"3.81","vol":"-4.22"},{"date":"2024-12-31","value":"1.11","vol":"1.15"},{"date":"2024-09-30","value":"-0.82","vol":"2.06"},{"date":"2024-06-30","value":"-2.76","vol":"2.35"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
5.10 | 3.81 | 1.11 | -0.82 | -2.76 |
| 行业(%) | -3.59 | -4.22 | 1.15 | 2.06 | 2.35 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"19.70","vol":"-58.56"},{"date":"2025-03-31","value":"80.38","vol":"-44.86"},{"date":"2024-12-31","value":"15.33","vol":"-25.85"},{"date":"2024-09-30","value":"-6.99","vol":"-50.40"},{"date":"2024-06-30","value":"-10.08","vol":"-16.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
19.70 | 80.38 | 15.33 | -6.99 | -10.08 |
| 行业(%) | -58.56 | -44.86 | -25.85 | -50.40 | -16.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 5/74 ， 13/74。
[{"date":"2025-06-30","value":"0.77","vol":"0.57"},{"date":"2025-03-31","value":"0.40","vol":"0.29"},{"date":"2024-12-31","value":"1.56","vol":"1.20"},{"date":"2024-09-30","value":"1.17","vol":"0.89"},{"date":"2024-06-30","value":"0.81","vol":"0.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.77 | 0.40 | 1.56 | 1.17 | 0.81 |
| 行业(次) | 0.57 | 0.29 | 1.20 | 0.89 | 0.58 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.29","vol":"2.88"},{"date":"2025-03-31","value":"1.71","vol":"1.42"},{"date":"2024-12-31","value":"6.52","vol":"6.07"},{"date":"2024-09-30","value":"5.36","vol":"4.52"},{"date":"2024-06-30","value":"3.71","vol":"2.99"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.29 | 1.71 | 6.52 | 5.36 | 3.71 |
| 行业(次) | 2.88 | 1.42 | 6.07 | 4.52 | 2.99 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 26/74 ， 32/74。
[{"date":"2025-06-30","value":"1.30","vol":"6.90"},{"date":"2025-03-31","value":"-7.92","vol":"0.70"},{"date":"2024-12-31","value":"14.96","vol":"13.18"},{"date":"2024-09-30","value":"1.50","vol":"4.01"},{"date":"2024-06-30","value":"1.23","vol":"6.62"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 1.30 | -7.92 | 14.96 | 1.50 | 1.23 |
| 行业 | 6.90 | 0.70 | 13.18 | 4.01 | 6.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.64","vol":"0.54"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.08","vol":"0.86"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.99","vol":"0.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.64 | - | 1.08 | - | 0.99 |
| 行业 | 0.54 | 0.00 | 0.86 | 0.00 | 0.77 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/74 ， 9/74。
[{"date":"2025-06-30","value":"1.25","vol":"1.41"},{"date":"2025-03-31","value":"1.26","vol":"1.44"},{"date":"2024-12-31","value":"1.27","vol":"1.44"},{"date":"2024-09-30","value":"1.27","vol":"1.47"},{"date":"2024-06-30","value":"1.24","vol":"1.44"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.25 | 1.26 | 1.27 | 1.27 | 1.24 |
| 行业 | 1.41 | 1.44 | 1.44 | 1.47 | 1.44 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.86","vol":"0.99"},{"date":"2025-03-31","value":"0.87","vol":"1.01"},{"date":"2024-12-31","value":"0.84","vol":"1.02"},{"date":"2024-09-30","value":"0.90","vol":"1.04"},{"date":"2024-06-30","value":"0.89","vol":"1.03"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.86 | 0.87 | 0.84 | 0.90 | 0.89 |
| 行业 | 0.99 | 1.01 | 1.02 | 1.04 | 1.03 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/74 ， 9/74。
[{"date":"2025-06-30","value":"67.97","vol":"62.27"},{"date":"2025-03-31","value":"68.06","vol":"61.71"},{"date":"2024-12-31","value":"67.19","vol":"62.27"},{"date":"2024-09-30","value":"67.52","vol":"61.64"},{"date":"2024-06-30","value":"69.01","vol":"59.27"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
67.97 | 68.06 | 67.19 | 67.52 | 69.01 |
| 行业(%) | 62.27 | 61.71 | 62.27 | 61.64 | 59.27 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.64","vol":"2.48"},{"date":"2025-03-31","value":"2.62","vol":"2.47"},{"date":"2024-12-31","value":"2.53","vol":"2.50"},{"date":"2024-09-30","value":"2.58","vol":"2.19"},{"date":"2024-06-30","value":"2.80","vol":"2.08"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.64 | 2.62 | 2.53 | 2.58 | 2.80 |
| 行业(%) | 2.48 | 2.47 | 2.50 | 2.19 | 2.08 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东方证券 | 2025-09-17 | 买入 | |
| 兴业证券 | 2025-09-08 | 增持 | |
| 中信建投证券 | 2025-09-05 | 买入 | |
| 东吴证券 | 2025-09-02 | 买入 | |
| 中国银河 | 2025-08-29 | 买入 | |
| 开源证券 | 2025-08-28 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"24.48","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"20.85","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"21.74","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"25.60","blueLineValue":"0.51","type":"YC"}]